Alex Therapeutics
Founded 2018 · 31 employees on LinkedIn · 5 known investors
Alex Therapeutics builds clinically validated digital therapeutics and therapy companion apps that combine CBT-based interventions, consumer product design, and AI/ML to support patients managing complex conditions such as rare diseases and cancer. It works as a health technology partner for life sciences and pharmaceutical companies developing regulated digital health products.
Founders & leadership
Alex Therapeutics was founded in 2018 by John Drakenberg and Oliver Fleetwood.
Investors · 5
Innovestor VenturesHelsinki · $270K – $3.2M
Hadean Venturesreported · 2 sourcesOslo
Scale Capitalreported · 2 sourcesCopenhagen · $1.1M – $7.6M
Also in the syndicate · 2
Bonit CapitalSweet Studio
In the news
Frequently asked questions
- What does Alex Therapeutics do?
- Alex Therapeutics builds clinically validated digital therapeutics and therapy companion apps that combine CBT-based interventions, consumer product design, and AI/ML to support patients managing complex conditions such as rare diseases and cancer. It works as a health technology partner for life sciences and pharmaceutical companies developing regulated digital health products.
- Who founded Alex Therapeutics?
- Alex Therapeutics was founded by John Drakenberg, Oliver Fleetwood in 2018.
- Who are Alex Therapeutics's investors?
- Alex Therapeutics's investors include Innovestor Ventures, Hadean Ventures, Scale Capital.